Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD

NCT04735263 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.

NCT NCT04735263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04735263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
Lead sponsor
Massachusetts Eye and Ear Infirmary
Phase
Phase 2
Overall status
Recruiting
Start date
February 4, 2021
Completion date
January 1, 2028
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration